International Biotechnology Trust PLC Biomarin Pharmaceutical Inc Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, International Biotechnology Trust PLC holds 153,656 shares of BMRN stock, worth $8.41 Million. This represents 4.61% of its overall portfolio holdings.

Number of Shares

153,656

Previous 58,656 161.96%

Holding current value

$8.41 Million

Previous $5.08 Million 167.41%

% of portfolio

4.61%

Previous 1.58%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $8.08 Million - $8.98 Million	95,000 Added 161.96%	153,656 $13.6 Million
Q1 2023 May 18, 2023	BUY	$87.74 - $117.27 $1.32 Million - $1.76 Million	15,000 Added 34.36%	58,656 $5.7 Million
Q4 2022 Feb 01, 2023	SELL	$80.93 - $108.63 $1.21 Million - $1.63 Million	-15,000 Reduced 25.57%	43,656 $4.52 Million
Q3 2022 Nov 08, 2022	BUY	$82.16 - $96.94 $4.28 Million - $5.05 Million	52,055 Added 788.59%	58,656 $4.97 Million
Q2 2022 Aug 16, 2022	SELL	$71.48 - $86.85 $5.22 Million - $6.34 Million	-73,055 Reduced 91.71%	6,601 $79.7 Million

Q1 2022 May 20, 2022	SELL	$74.28 - $92.69 $1.89 Million - $2.36 Million	-25,500 Reduced 24.25%	79,656 $6.14 Million
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $3.59 Million - $4.57 Million	50,000 Added 90.65%	105,156 $9.29 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $14.4 Million - $17.5 Million	-192,428 Reduced 77.72%	55,156 $4.17 Million
Q3 2020 Dec 01, 2020	BUY	$71.87 - $131.03 $4.46 Million - $8.12 Million	62,000 Added 33.41%	247,584 $18.8 Million
Q2 2020 Jul 14, 2020	BUY	$79.55 - $124.22 $1.26 Million - $1.96 Million	15,800 Added 9.31%	185,584 $22.7 Million
Q1 2020 May 18, 2020	BUY	$71.37 - $96.85 $4.67 Million - $6.34 Million	65,500 Added 62.81%	169,784 $14.3 Million
Q4 2019 May 18, 2020	BUY	$64.27 - $86.37 $1.09 Million - $1.47 Million	17,000 Added 19.48%	104,284 $8.81 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $1.55 Million - $1.96 Million	23,000 Added 35.78%	87,284 $5.88 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $2.36 Million - $2.76 Million	-28,000 Reduced 30.34%	64,284 $5.7 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $400,700 - $530,350	-5,000 Reduced 5.14%	92,284 $6.18 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $4.48 Million - $5.04 Million	-47,716 Reduced 32.91%	97,284 $7.23 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $4.48 Million - $5.04 Million	47,716 Added 49.05%	145,000 $1.23 Million
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $2.43 Million - $3.17 Million	32,000 Added 49.02%	97,284 $9.16 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $240,777 - $287,153	-3,100 Reduced 4.53%	65,284 $5.29 Million
Q3 2017 Mar 02, 2018	SELL	$80.6 - $94.95 $4.01 Million - $4.73 Million	-49,782 Reduced 42.13%	68,384 $6.36 Million
Q2 2017 Mar 02, 2018	BUY	N/A	40,500 Added 52.15%	118,166 $10.7 Million
Q1 2017 Mar 02, 2018	BUY	N/A	2,000 Added 2.64%	77,666 $6.82 Million
Q4 2016 Mar 02, 2018	BUY	N/A	75,666	75,666 $6.27 Million

Others Institutions Holding BMRN

# of Institutions

654

Shares Held

182M

Call Options Held

1.48M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Biomarin Pharmaceutical Inc Transaction History